Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

Elan names Robert Ingram as new chairman

December 10, 2010 Research and Development, Sales and Marketing Elan, appointment, research and development, sales and marketing

Elan has appointed former Glaxo Wellcome chief executive Robert Ingram as its chairman-designate. Ingram led Glaxo between 1997 and 2000 …
Appointment

Valuing medicines and NHS reform – the ABPI view

December 10, 2010 Sales and Marketing ABPI, NHS reforms, Paul Catchpole, market access, value-based pricing

For those concerned with improving the value for money of medicines to the UK’s health service, the government’s White Paper …
Feature
Andrew Lansley

First GP consortia named

December 9, 2010 Sales and Marketing Lansley, NHS, consortia, reforms

The first consortia of GPs who will spearhead England’s healthcare reforms have been unveiled. A total of 52 consortia from …
News

GSK acquires China’s Nanjing MeiRui Pharma for $70m

December 8, 2010 Manufacturing and Production, Sales and Marketing China, GSK, GlaxoSmithKline, Nanjing MeiRui Pharma, Pagoda Pharmaceuticals, SheNiTing

GlaxoSmithKline has continued its expansion into China with the $70 million acquisition of a local firm. Nanjing MeiRui Pharma Co’s …
News
Avastin packs

NICE no for Avastin in breast cancer

December 8, 2010 Sales and Marketing NICE, Roche, avastin, bevacizumab, breast cancer, health technology assessment, hta

NICE has refused to back Roche’s Avastin for use in breast cancer patients citing the blockbuster drug’s high cost and …
News

Trial hitch for Pfizer’s leukaemia drug submission plans

December 7, 2010 Research and Development, Sales and Marketing CML, Gleevec, Glivec, Pfizer, bosutinib, chronic myeloid leukaemia

Pfizer is pressing ahead with plans to submit bosutinib for European approval despite the chronic myeloid leukaemia drug missing its …
News

AZ’s Brilique approved in Europe

December 7, 2010 Sales and Marketing AZ, AstraZeneca, Brilique, Plavix, acute coronary syndromes, antiplatelet, atherothrombotic events, ticagrelor

European regulator have approved AstraZeneca’s oral antiplatelet Brilique (ticagrelor tablets). Brilique can now be used for the prevention of atherothrombotic …
News
EU flag

EU regulators launch fresh raids on pharma

December 7, 2010 Sales and Marketing AstraZeneca, European Commission, Losec, Nexium, Nycomed, Pantazol, Ratiopharm, antitrust investigation, esomeprazole, pantoprazole

Competition regulators from the EU have raided offices of AstraZeneca and Nycomed in connection with alleged attempts to block generic …
News

Laura Lane joins Black Swan

December 6, 2010 Sales and Marketing Black Swan Analysis, Laura Lane, appointment, sales and marketing

Black Swan Analysis has appointed Dr Laura Lane to its Analysis and Forecasting team.Laura brings with her a strong scientific …
Appointment

Roche’s MabThera successor shows phase II promise

December 6, 2010 Research and Development, Sales and Marketing GA101, Genentech, GlycArt, MabThera, Roche, blood cancer, chronic lymphocytic leukaemia

The cancer drug Roche is developing as a second-generation successor to its blockbuster MabThera has shown promising results in a …
News

Surprise exit for Pfizer chief executive Jeffrey Kindler

December 6, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Ian Read, Jeffrey Kindler, Lipitor, Pfizer, Wyeth, executive succession

Pfizer’s chief executive Jeffrey Kindler has unexpectedly stepped down, saying his time at the helm of the world’s largest pharmaceutical …
News
Roche's MabThera

NICE recommends MabThera for non-Hodgkin’s lymphoma

December 6, 2010 Sales and Marketing MabThera, NICE, Rituxan, Roche, non-Hodgkin’s lymphoma, rituximab

NICE has given a preliminary green-light to Roche’s MabThera for use as a maintenance therapy for non-Hodgkin’s lymphoma. The Institute’s …
News

A mature approach to relationships with pharma’s customers

December 6, 2010 Sales and Marketing MSI, Paul Stuart Kregor, franchise management, pharma marketing

Commercial managers who are responsible for a number of brands face a constant challenge in choosing where across the franchise …
Feature

Apitope appoints Hayley French

December 6, 2010 Research and Development, Sales and Marketing Apitope, Hayley French, appointment, research and development, sales and marketing

Belgium-based biopharmaceutical company Apitope has appointed Hayley French to its management team as commercial director. She will be responsible for …
Appointment

The specifics of early access programmes

December 3, 2010 Sales and Marketing Expanded Access Programs, IDIS, early access programmes, named patient programmes

With increasing requests from healthcare professionals and patients globally for access to drugs that are still in clinical development or …
Feature
The Gateway to Local Adoption Series

Latest content

Closing the immunisation gap: partnership working that delivered at scale

June 3, 2026

China approves fruquintinib combination for kidney cancer

May 29, 2026

BIOTRONIK, Charité and GHCF launch digital cardiology partnership

May 28, 2026

Endometriosis study begins recruitment in UK hospitals

May 28, 2026

MHRA authorises donidalorsen for hereditary angioedema prevention

May 27, 2026